Optimal use of pegvisomant in acromegaly: are we getting there?
Crossref DOI link: https://doi.org/10.1007/s12020-014-0462-0
Published Online: 2014-10-28
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Giustina, Andrea
Text and Data Mining valid from 2014-10-28